Khattar Jack A.

CIK 00015399374 companiesROCKVILLE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001539937

Recent Transactions

50 trades

Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-10-09$50.55/sh−58,371→ 1,208,107 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-10-09$51.46/sh−1,529→ 1,206,578 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-10-09$25.30/sh+81,250→ 1,266,478 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2025-10-09−81,250→ 0 total
Disposition from Tender
scPharmaceuticals Inc.$SCPH
Common Stock
2025-10-07−5,000→ 0 total
Disposition to Issuer
scPharmaceuticals Inc.$SCPH
Stock Option (Right to Buy)
2025-10-07−16,300→ 0 total
Disposition to Issuer
scPharmaceuticals Inc.$SCPH
Stock Option (Right to Buy)
2025-10-07−30,000→ 0 total
Disposition to Issuer
scPharmaceuticals Inc.$SCPH
Stock Option (Right to Buy)
2025-10-07−19,750→ 0 total
Disposition to Issuer
scPharmaceuticals Inc.$SCPH
Stock Option (Right to Buy)
2025-10-07−6,124→ 0 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-10-02$46.21/sh−7,529→ 1,185,228 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-10-02$25.30/sh+2,267→ 1,163,137 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-10-02$48.06/sh−1,904→ 1,161,233 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-10-02+20,000→ 1,181,233 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-10-02$46.21/sh−7,796→ 1,173,437 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2025-10-02−2,267→ 81,250 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Units
2025-10-02−19,320→ 0 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-10-02+19,320→ 1,192,757 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2025-10-02−20,000→ 0 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-10-01$48.07/sh−40,173→ 1,160,870 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-10-01$25.30/sh+53,785→ 1,201,043 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2025-10-01−53,785→ 83,517 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-09-30$25.30/sh+11,510→ 1,155,846 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2025-09-30−11,510→ 137,302 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-09-30$48.25/sh−8,588→ 1,147,258 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-09-29$48.02/sh−10,235→ 1,144,336 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-09-29$25.30/sh+13,688→ 1,154,571 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2025-09-29−13,688→ 148,812 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2025-09-23−47,940→ 0 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-09-23$12.98/sh+47,940→ 1,170,396 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-09-23$47.23/sh−29,513→ 1,140,883 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-09-22$47.02/sh−16,587→ 1,122,456 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-09-22$12.98/sh+27,060→ 1,139,043 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2025-09-22−27,060→ 47,940 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2025-09-10+20,000→ 20,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Units
2025-09-10+19,320→ 19,320 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-09-08$25.30/sh+8,074→ 1,118,305 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-09-08$46.29/sh−6,322→ 1,111,983 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2025-09-08−8,074→ 162,500 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-09-05$25.30/sh+73,176→ 1,165,809 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-09-05$46.01/sh−55,578→ 1,110,231 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2025-09-05−73,176→ 170,574 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-08-28$12.98/sh+38,779→ 1,116,783 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2025-08-28−38,779→ 75,000 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-08-28$45.12/sh−24,150→ 1,092,633 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-08-27$45.05/sh−10,650→ 1,078,004 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-08-27$12.98/sh+17,195→ 1,088,654 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2025-08-27−17,195→ 113,779 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2025-08-25−1,611→ 130,974 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-08-25$12.98/sh+1,611→ 1,072,459 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-08-25$45.00/sh−1,000→ 1,071,459 total

Companies

Recent Filings

Address

C/O SUPERNUS PHARMACEUTICALS, INC. 1550 EAST GUDE DRIVE

ROCKVILLE, MD, 20850

View on SEC.gov